Literature DB >> 3323640

A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.

J Müller-Quernheim1, R E Schopf, P Benes, V Schulz, R Ferlinz.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease of unknown etiology. Macrophage dysfunctions are claimed to be involved in the pathogenesis. We investigated phagocytosis and oxidative metabolism of alveolar macrophages in a case of pulmonary alveolar proteinosis. These cells phagocytize normally and phagocytizable stimulants cause a normal oxidative burst. In response to the membrane signals phorbolmyristate acetate and aggregated immunoglobulin, however, no stimulated turnover of the oxidative metabolism can be observed. A 40-kD protein found in the lavage fluid mediates this macrophage-inhibiting effect. This phenomenon may contribute to the frequent opportunistic infections seen in PAP patients. It can be concluded from our data that the high frequency of infections with opportunistic species in these patients can be reduced by therapeutic bronchoalveolar lavage. By this procedure the abnormal macrophage-suppressing protein can be washed out of the lung at an early stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323640     DOI: 10.1007/BF01745499

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  23 in total

1.  PULMONARY ALVEOLAR PROTEINOSIS. REPORT OF SIX CASES, REVIEW OF THE LITERATURE, AND FORMULATION OF A NEW THEORY.

Authors:  R K LARSON; R GORDINIER
Journal:  Ann Intern Med       Date:  1965-02       Impact factor: 25.391

2.  Alveolar proteinosis.

Authors:  J B LOVETTE; G J MAGOVERN; E M KENT
Journal:  Arch Intern Med       Date:  1961-10

3.  Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG.

Authors:  J E Lehmeyer; R B Johnston
Journal:  Clin Immunol Immunopathol       Date:  1978-04

4.  Pulmonary alveolar proteinosis.

Authors:  J B McClenahan
Journal:  Arch Intern Med       Date:  1974-02

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Pulmonary alveolar proteinosis. Nature and origin of alveolar lipid.

Authors:  J Ramirez; W R Harlan
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

Review 7.  Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis).

Authors:  W D Claypool; R M Rogers; G M Matuschak
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

8.  Structure elucidation by one- and two-dimensional 360- and 500-MHz 1H NMR of the oligosaccharide units of two glycoproteins isolated from alveoli of patients with alveolar proteinosis.

Authors:  S N Bhattacharyya; W S Lynn; J Dabrowski; K Trauner; W E Hull
Journal:  Arch Biochem Biophys       Date:  1984-05-15       Impact factor: 4.013

9.  Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte, and platelet function by phorbol diesters.

Authors:  B J Goodwin; J B Weinberg
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  Alveolar proteinosis: diagnosis and treatment over a 10-year period.

Authors:  R M Du Bois; W A McAllister; M A Branthwaite
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.